Major Projects
Funds ambitious, high-impact research projects advancing dementia treatment, diagnosis, or prevention, supporting innovative clinical and translational science in line with Alzheimer's Research UK’s priorities.
Funder: Alzheimer's Research UK
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Flexible funding up to £750,000; project duration up to 5 years.
Summary: Supports ambitious, high-impact dementia research projects in treatment, diagnosis, or prevention, with flexible budgets and duration.
Key Information: Lead applicant must be based at a UK academic/research institution; international collaborators allowed.
Description
This grant scheme funds intermediate to large-scale research projects that advance the treatment, diagnosis, or prevention of dementia, in alignment with Alzheimer's Research UK’s strategic priorities. The scheme encourages bold, innovative, and high-impact proposals driven by scientific opportunity rather than a strict budget cap. Both clinical and translational research are welcomed, with a particular focus on work accelerating progress toward a cure. Funding can also support “added value” sub-studies of existing or planned clinical trials (excluding core trial costs), such as biomarker validation or digital outcome measures. The scheme offers flexible support for salaries, experimental costs, equipment, and collaborative expenses, with a maximum award of £750,000 and project durations of up to five years.
